Searched for
GENZYME
IGST a bitter pill for patients with rare disorders as medicines attract 5%-12%While life-saving medicines imported for personal use would continue to be exempt from basic customs duty, they are not exempt from IGST.05 Aug, 2017, 11.39 AM IST- Dr Reddy's plunges nearly 2% on patent infringement suitDr Reddy's Laboratories plunged as much as 1.85% in a weak market on Monday after Genzyme Corporation filed a suit against the company.23 Sep, 2013, 10.00 AM IST
- Genzyme Corporation files patent infringement suit against DRLMozobil (plerixafor injection) is a hematopoietic stem cell mobiliser indicated to patients with non-Hodgkin's lymphoma (blood cancer) and ...22 Sep, 2013, 01.30 PM IST
- Genzyme signs deal with SIAMG to train doctors in geneticsGenzyme, announced a tie-up with the Society for Indian Academy of Medical Genetics, for a joint fellowship program for Indian doctors.08 Apr, 2013, 06.37 PM IST
- Glenmark settles patent row with Daiichi, GenzymeGlenmark Pharmaceuticals on Monday said it has settled a patent infringement litigation with Daiichi Sankyo and Genzyme.05 Jul, 2011, 05.50 AM IST
- Glenmark settles patent infringement litigation with Daiichi, GenzymeThe company has received a licence from Daiichi Sankyo and Genzyme that will permit it to launch its generic Colesevelam Hydrochloride prod...04 Jul, 2011, 02.22 PM IST
- Glenmark settles litigation with Daiichi Sankyo; stock upGlenmark Pharmaceuticals has reached at a settlement agreement with Daiichi Sankyo, Inc and Genzyme Corporation in regards with Glenmark’s ...04 Jul, 2011, 12.21 PM IST
- Sanofi extends $18.5 bn bid for Genzyme againIn a statement Sanofi-aventis said its offer of $69 per Genzyme share was extended till February 15 midnight.24 Jan, 2011, 03.55 PM IST
- Sanofi extends $18.5bn offer for Genzyme till Jan 21Sanofi-aventis has a significant presence in India. Last year, Sanofi-aventis had sought to acquire an 80pc stake in ShanthaBiotechnics for...13 Dec, 2010, 02.24 PM IST
- Sanofi extends bid for GenzymeFrench pharmaceutical giant Sanofi-Aventis said Monday it had extended its bid for US biotechnology group Genzyme without improving the off...13 Dec, 2010, 12.08 PM IST
- Genzyme board rejects Sanofi $69-a-share offerBiotech firm Genzyme Corp. says its board of directors is rejecting Sanofi-Aventis SA's $69 a share offer and recommending Genzyme sharehol...08 Oct, 2010, 04.13 AM IST
- Genzyme plans to cut 1000 jobs over next 15 monthsCambridge-based biotechnology company Genzyme, which rejected a $ 18.5 bn takeover offer from French pharma giant Sanofi Aventis, plans to ...11 Sep, 2010, 10.38 PM IST
- Sanofi-Aventis likely to buy Genzyme for USD 19 bn: ReportFrench drug maker Sanofi-Aventis is likely to make an formal offer to acquire US-based biotech company Genzyme for USD 19 billion, says a m...29 Jul, 2010, 02.18 PM IST
- Mitra Biotech gets VC fundingThe Bangalore-based Mitra Biotech, a biology research firm and spin-off from MIT, US, has received venture capital funding from Accel Partn...27 Apr, 2010, 01.52 AM IST
- ‘Innovation can only be funded by branded therapies’In an e-mail interview with ET, Henri A Termeer, Chairman, President & CEO of Genzyme Corporation discusses the latest trends in the area o...22 Jan, 2009, 03.24 AM IST
- Genzyme to set up R&D centres in IndiaThe company also plans to bring its complete range of global pipeline used to treat ultra rare diseases and set up research and manufacturi...20 Nov, 2008, 01.54 AM IST
- Tata co ties up with Genzyme, Medicines for Malaria VentureAdvinus Therapeutics, a Bangalore-based research pharma company promoted by the Tata group, has announced a new collaboration with Genzyme ...26 Aug, 2008, 12.17 AM IST
Load More
